Cascella Robert reported grant involving 36,250 shares of Neuronetics, Inc. at $0.00 for $0 on May 28, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed May 29, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
36,250Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
625,017Direct
Trade date
May 28, 2026Grant
Filed
May 29, 2026, 5:01 PM ET1-day reporting delay
Accession
0001218713-26-000002Code A · Transaction 96465
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

STIM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
STIM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +6.5%1w ago −23%1d ago −21%
Returns since7d −16%30d −13%90d180d1y

Footnotes in full

F1: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.